Publications
Specialty
Search
Journal of Clinical Pathways
06/04/2024
William J. Gradishar, MD, details the latest advancements in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) breast cancer.
First Report Managed Care
06/04/2024
The ever evolving and pervasive digital ecosystem has transformed the way consumers research, engage, and transact—with more transparency and efficiency than ever before. And as health care digital transformation continues, consumers are expecting the same experiences when they consume health care as well. In this commentary, Clay Ritchey, CEO, Verato, offers insights into the benefits of improved identity management to improve the patient experience.
Neurology
06/04/2024
Intravenous tirofiban decreased the risk of early neurological deterioration in patients with acute noncardioembolic stroke without an increased risk of symptomatic intracerebral hemorrhage or systematic bleeding, according to study results published in JAMA Neurology.
Oncology
06/04/2024
David Andorsky, MD, shares expert insight on the significance of clinical trials in lymphoma research, focusing on the inclusion of older patients in these studies.
Oncology
06/04/2024
Results from a phase 2 study found that ceralasertib plus olaparib was well tolerated and demonstrated promising clinical activity among patients with recurrent platinum-sensitive ovarian cancer, regardless of tumor genomic instability.
Oncology
06/04/2024
John Burke, MD, discusses some of the most compelling topics in diffuse large B-cell lymphoma and mantle cell lymphoma research presented at the 2024 ASCO Annual Meeting.
EMSWorld
06/04/2024
Given ongoing crises in America’s emergency departments—short staffing, stress and burnout, overcrowding and patient boarding, and more—it's important to explore alternatives to traditional emergency rooms.
EMSWorld
06/04/2024
Given ongoing crises in America’s emergency departments—short staffing, stress and burnout, overcrowding and patient boarding, and more—it's important to explore alternatives to traditional emergency rooms.
Rheumatology & Arthritis
06/04/2024
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
Vascular Disease Management
06/04/2024
Gary Ansel, MD, Sean Lyden, MD, Lucas Ferrer Cardona, MD and Dean Ferrera, DO describe the impact of the Pounce™ Thrombectomy System on the removal of peripheral arterial thrombi and emboli.
Oncology
06/03/2024
Xichun Hu, MD, PhD, Fudan University Cancer Institute, Shangai, China, discussed results from the DESTINY-Breast06 trial which identified trastuzumab deruxtecan as a potential new standard of care for patients with HER2-Low metastatic breast cancer who previously underwent endocrine therapy.
Journal of Clinical Pathways
06/03/2024
This column discusses how there is a stakeholder disconnect in precision medicine, leaving employers and other commercial plans or administrators seeking solutions as they face emerging risks from precision therapies.
ePlasty, Surgery
06/03/2024
This report describes an innovative but simple technique for the repair of medial canthus injury involving canaliculus.
Journal of Clinical Pathways
06/03/2024
This entry of our MAI Mindset column summarizes the third part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
Oncology
06/03/2024
Don Dizon, MD, discusses the results from the phase 2 BrUOG 354 trial evaluating nivolumab with/without ipilimumab among patients with ovarian and extra-renal clear cell carcinoma.
Oncology
06/03/2024
Jane Meisel, MD, discussed results from the I-SPY 2.2 trial which investigated the clinical activity of datopotamab deruxtecan among patients with HR-positive, HER2-negative breast cancer.
Journal of Clinical Pathways
06/03/2024
In this roundtable, part of a content partnership between Journal of Clinical Pathways and Flatiron Health, participants discussed how to develop and implement clinical pathways at cancer centers.
Journal of Clinical Pathways
06/03/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these entities contribute to the current high costs of care in the US and how they can help control those costs for patients.
Cancer Care Business Exchange, Journal of Clinical Pathways, Clinical Pathways
06/03/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the key problems people have with health care in the US.
Oncology
06/03/2024
According to phase 2 data, sintilimab plus paclitaxel and cisplatin in the neoadjuvant setting showed encouraging antitumor activity among patients with locally advanced cervical cancer.